Howard Liu

1.6k total citations
43 papers, 555 citations indexed

About

Howard Liu is a scholar working on Surgery, Oncology and Otorhinolaryngology. According to data from OpenAlex, Howard Liu has authored 43 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 20 papers in Oncology and 16 papers in Otorhinolaryngology. Recurrent topics in Howard Liu's work include Head and Neck Cancer Studies (16 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Howard Liu is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Howard Liu collaborates with scholars based in Australia, United States and United Kingdom. Howard Liu's co-authors include Karin Steinke, Sandro Porceddu, David Pryor, Benedict Panizza, Aleta L. Svitak, John R. Fawcett, Kathy Merlock Jackson, William H. Frey, Mathias Bressel and Jennifer M. Peterson and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Howard Liu

36 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Howard Liu Australia	13	202	198	124	116	109	43	555
Mariachiara Santorsola Italy	13	218 1.1×	92 0.5×	21 0.2×	85 0.7×	121 1.1×	45	428
Jiansheng Li China	12	144 0.7×	54 0.3×	31 0.3×	77 0.7×	138 1.3×	29	396
Yu Heng China	15	200 1.0×	140 0.7×	79 0.6×	177 1.5×	212 1.9×	59	651
Guo Long China	13	170 0.8×	152 0.8×	15 0.1×	60 0.5×	213 2.0×	26	492
Matthias Geiger Germany	9	134 0.7×	46 0.2×	81 0.7×	97 0.8×	137 1.3×	10	464
Jing‐Yun Wen China	13	255 1.3×	81 0.4×	18 0.1×	67 0.6×	172 1.6×	36	594
Bojin Su China	8	101 0.5×	85 0.4×	18 0.1×	33 0.3×	300 2.8×	13	473
Manali Rupji United States	13	165 0.8×	111 0.6×	14 0.1×	65 0.6×	186 1.7×	45	479
Tomotaka Shibata Japan	18	189 0.9×	276 1.4×	20 0.2×	306 2.6×	322 3.0×	51	722
Shinichiro Shimamatsu Japan	12	352 1.7×	277 1.4×	11 0.1×	51 0.4×	175 1.6×	40	580

Countries citing papers authored by Howard Liu

Since Specialization

Citations

This map shows the geographic impact of Howard Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Liu more than expected).

Fields of papers citing papers by Howard Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Liu. The network helps show where Howard Liu may publish in the future.

Co-authorship network of co-authors of Howard Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Liu. A scholar is included among the top collaborators of Howard Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Liu. Howard Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ladwa, Rahul, Jenny Lee, Caroline Cooper, et al.. (2025). Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study. Journal of Clinical Oncology. 43(26). 2888–2896. 1 indexed citations

Liu, Jia, Howard Liu, Steven G. Williams, et al.. (2025). A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence. Cancer Research Communications. 5(4). 580–593. 1 indexed citations

Porceddu, Sandro, Emma Connolly, Mathias Bressel, et al.. (2025). Prognostic Subgroups for Disease-Free Survival With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngology–Head & Neck Surgery. 151(10). 938–938.

Ye, Tianzheng, Tian Wang, Howard Liu, et al.. (2025). Programmable protein stabilization with language model-derived peptide guides. Nature Communications. 16(1). 3555–3555.

Liu, Howard, et al.. (2025). Hypofractionated adjuvant radiotherapy in cutaneous squamous cell and basal cell carcinoma of the head and neck: 50(Gy) in 20 study. Oral Oncology Reports. 13. 100732–100732.

Ladwa, Rahul, James Monkman, Caroline Cooper, et al.. (2023). 1144P High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. Annals of Oncology. 34. S685–S685.

Liu, Howard, Yoo-Young Lee, Swetha Sridharan, et al.. (2023). Definitive Stereotactic Body Radiation Therapy in Early-Stage Solitary Hepatocellular Carcinoma: An Australian Multi-Institutional Review of Outcomes. Clinical Oncology. 35(12). 787–793. 4 indexed citations

Ghanem, A.I., N.M. Woody, Nikhil Joshi, et al.. (2022). Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study. Oral Oncology. 126. 105781–105781. 4 indexed citations

Pigott, Amanda, Bena Brown, Nicole White, et al.. (2022). A prospective observational cohort study examining the development of head and neck lymphedema from the time of diagnosis. Asia-Pacific Journal of Clinical Oncology. 19(4). 473–481. 5 indexed citations

10.

Siva, Shankar, Mathias Bressel, Simon Wood, et al.. (2021). Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial. European Urology. 81(4). 364–372. 84 indexed citations

11.

Neller, Michelle A., Sriganesh Srihari, Pauline Crooks, et al.. (2020). Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients. The Journal of Experimental Medicine. 217(10). 44 indexed citations

12.

Masterson, Liam, James Howard, Jazmina L. Gonzalez Cruz, et al.. (2020). Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?. International Journal of Cancer. 146(8). 2305–2314. 52 indexed citations

13.

Liu, Howard, Anne Bernard, Matthew Foote, et al.. (2020). The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer. Radiotherapy and Oncology. 151. 242–248. 3 indexed citations

14.

Liu, Howard, David Leggett, Peter Hodgkinson, et al.. (2020). Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma – Initial Experience From an Australian Liver Cancer Service. Clinical Oncology. 32(10). e194–e202. 20 indexed citations

15.

Porceddu, Sandro, Sue S. Yom, Howard Liu, et al.. (2020). Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN). International Journal of Radiation Oncology*Biology*Physics. 107(4). 641–651. 25 indexed citations

16.

Brown, Elizabeth, et al.. (2020). Intrafraction cone beam computed tomography verification of breath hold during liver stereotactic radiation therapy. Journal of Medical Radiation Sciences. 68(1). 52–59. 12 indexed citations

17.

Solomon, Benjamin, Richard J. Young, Mathias Bressel, et al.. (2019). Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance. Annals of Oncology. 30(10). 1638–1646. 30 indexed citations

18.

Young, Richard J., Mathias Bressel, Sandro Porceddu, et al.. (2019). Validation and characterisation of prognostically significant PD-L1+ immune cells in HPV+ oropharyngeal squamous cell carcinoma. Oral Oncology. 101. 104516–104516. 20 indexed citations

19.

Liu, Howard, Benedict Panizza, Anne Bernard, et al.. (2018). Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy. Oral Oncology. 88. 153–159. 35 indexed citations

20.

Fawcett, John R., Kathy Merlock Jackson, Howard Liu, et al.. (2002). Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer’s brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants. Brain Research. 950(1-2). 10–20. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact